CLASS II Device recall · Reported 5 Jun 2019 · FDA Enforcement Report

McKesson Cardiology Hemo recalled by Change Healthcare Israel

Change Healthcare Israel is recalling McKesson Cardiology Hemo, distributed nationwide in the US. The recall was initiated on 25 Mar 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSoftware version 13.x
Quantity recalled1,383 devices

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1490-2019
FDA event ID
82600
Recalling firm
Change Healthcare Israel, Holon, N/A
Classification
Class II
Status
Terminated
Recall initiated
25 Mar 2019
FDA classified
24 May 2019
Reported
5 Jun 2019
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

25 Mar 2019Recall initiated by company
24 May 2019Classified by FDA+60 days
5 Jun 2019Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

users are not notified of procedure medication discrepancies between the Vitals and Meds, the Procedure Notes and Patient Common Data screens in Horizon/McKesson Cardiology Hemo" (Hemo). The discrepancy may also affect administered medication data in reports generated from Hemo or the Horizon/McKesson Cardiology Physician s Report as well as customers, who have implemented an outbound interface of procedure results.

Product as listed by the FDA

McKesson Cardiology Hemo

Where it was distributed

Nationwide distribution to AK, AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WV, WY. International distribution to Australia, Canada, Germany, Ireland, Israel, United Kingdom.

Nationwide AlaskaAlabamaArkansasArizonaCaliforniaColoradoConnecticutFloridaGeorgiaHawaiiIowaIdahoIllinoisIndianaKansasKentuckyLouisianaMassachusettsMarylandMaine

Questions about this recall

Is McKesson Cardiology Hemo recalled?

Yes. Change Healthcare Israel recalled McKesson Cardiology Hemo on 25 Mar 2019. The recall is Class II and its status is Terminated. Recall number Z-1490-2019.

Why was it recalled?

users are not notified of procedure medication discrepancies between the Vitals and Meds, the Procedure Notes and Patient Common Data screens in Horizon/McKesson Cardiology Hemo" (Hemo). The discrepancy may also affect administered medication data in reports generated from Hemo or the Horizon/McKesson Cardiology Physician s Report as well as customers, who have implemented an outbound interface of procedure results.

Which lots are affected?

Software version 13.x

Where was it sold?

Nationwide distribution to AK, AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WV, WY. International distribution to Australia, Canada, Germany, Ireland, Israel, United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Change Healthcare Israel

All 2
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IIHorizon Cardiology Hemo recalled by Change Healthcare IsraelChange Healthcare IsraelOtherNationwide

Other Other Medical Devices recalls

All 13,778